德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

已收盘 12-19 16:08:06

4.050

+0.100

+2.53%

最高4.120	最低3.940	成交量140.20万
今开3.970	昨收3.950	日振幅4.56%
总市值27.50亿	流通市值27.50亿	总股本6.79亿
成交额567.22万	换手率0.21%	流通股本6.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":4.05,"timestamp":1766131686010,"preClose":3.95,"halted":0,"volume":1402000,"delay":0,"floatShares":679000000,"shares":679000000,"eps":-0.5690339764705883,"marketStatus":"已收盘","change":0.1,"latestTime":"12-19 16:08:06","open":3.97,"high":4.12,"low":3.94,"amount":5672220,"amplitude":0.04557,"askPrice":4.06,"askSize":75500,"bidPrice":4.04,"bidSize":40000,"shortable":3,"etf":0,"ttmEps":-0.4069691294117647,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":3.95,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":0.866986,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996/tweets","defaultTab":"tweets","newsList":[{"id":"2592947699","title":"每日卖空追踪 | 德琪医药-B 12月17日卖空量成交12.2万股，卖空比例为9.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592947699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592947699?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960237,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月17日，跌0.5%，卖空量成交12.2万股，较上一交易日减少20%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163630a4561541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163630a4561541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1583","06996"],"gpt_icon":0},{"id":"2592556129","title":"智通港股早知道 | 欧盟拟放宽内燃机禁令 道指、标普连跌三日","url":"https://stock-news.laohu8.com/highlight/detail?id=2592556129","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592556129?lang=zh_cn&edition=full","pubTime":"2025-12-17 07:29","pubTimestamp":1765927794,"startTime":"0","endTime":"0","summary":"活动上，中国石化上市公司市值提升专项行动启动。美股道指、标普连跌三日 大型科技股多数上涨隔夜美股道指、标普连跌三日。欧盟拟放宽内燃机禁令 汽车制造商迎喘息之机智通财经APP获悉，在汽车行业数月的压力之下，欧盟准备提议放宽对新车的排放规定，实际上废除对燃油发动机的禁令。进口环节增值税以海关确定进口货物的计税价格加上关税和反倾销税作为计税价格从价计征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ESmain","BK1191","06996","BK1522","LU2242644610.SGD","LU0449509016.USD","SDOW","BK1583","DXD","DOG","LU0214875030.USD","03899","FSXEmain","BK1183","YMmain",".DJI","DJX","LU0449515922.USD","DDM","SG9999004220.SGD","UDOW","MYMmain","BK1574","FESXmain","LU0054450605.USD"],"gpt_icon":0},{"id":"2592535749","title":"德琪医药-B(06996)：希维奥®在马来西亚获批用于治疗弥漫大B细胞淋巴瘤一种新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2592535749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592535749?lang=zh_cn&edition=full","pubTime":"2025-12-17 06:49","pubTimestamp":1765925353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，马来西亚国家药品监督管理署已批准希维奥®(塞利尼索)的一项补充新药上市申请(sNDA)，批准希维奥®用于治疗接受过至少两线系统性治疗且不符合自体干细胞移植的复发性或难治性弥漫大B细胞淋巴瘤(DLBCL)成人患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B(06996)：希维奥®在马来西亚获批用于治疗弥漫大B细胞淋巴瘤一种新适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"1176093720","title":"德琪医药-B - 马来西亚国家药品监管局已批准Xpovio用于复发性或难治性DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=1176093720","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176093720?lang=zh_cn&edition=full","pubTime":"2025-12-17 06:07","pubTimestamp":1765922852,"startTime":"0","endTime":"0","summary":"德琪医药-B - 马来西亚国家药品监管局已批准Xpovio用于复发性或难治性DLBCL","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2591260776","title":"每日卖空追踪 | 德琪医药-B 12月16日卖空量成交10.6万股，卖空比例为4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591260776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591260776?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873835,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月16日，跌3.38%，卖空量成交10.6万股，较上一交易日减少41.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163614a451a0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163614a451a0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1191","06996"],"gpt_icon":0},{"id":"2591607200","title":"德琪医药-B12月16日遭主力抛售53.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591607200?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872945,"startTime":"0","endTime":"0","summary":"12月16日, 德琪医药-B股价跌3.38%，报收4.00元，成交金额877.9万元，换手率0.32%，振幅6.04%，量比1.25。德琪医药-B今日主力资金净流出53.5万元，上一交易日主力净流出65.6万元。该股近5个交易日下跌8.66%，主力资金累计净流出51.5万元；近20日主力资金累计净流出381.8万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162001a6a8a52c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162001a6a8a52c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2590197625","title":"德琪医药-B12月11日主力净流出41.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590197625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590197625?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440944,"startTime":"0","endTime":"0","summary":"12月11日, 德琪医药-B股价跌4.92%，报收4.25元，成交金额975.4万元，换手率0.33%，振幅6.94%，量比1.15。德琪医药-B今日主力资金净流出41.4万元，上一交易日主力净流入95.0万元。该股近5个交易日下跌2.07%，主力资金累计净流入4.9万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出393.6万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161955a6990bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161955a6990bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2590780531","title":"每日卖空追踪 | 德琪医药-B 12月10日卖空量成交32.15万股，卖空比例为12.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590780531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590780531?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355437,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月10日，涨1.82%，卖空量成交32.15万股，较上一交易日增加183.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016364395353e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016364395353e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2590317385","title":"德琪医药-B12月10日主力净流入95.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590317385","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590317385?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354535,"startTime":"0","endTime":"0","summary":"12月10日, 德琪医药-B股价涨1.82%，报收4.47元，成交金额1106.5万元，换手率0.37%，振幅3.64%，量比1.06。德琪医药-B今日主力资金净流入95.0万元，上一交易日主力净流出107.9万元。该股近5个交易日上涨7.28%，主力资金累计净流入142.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出240.0万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016174895353441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016174895353441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2590362159","title":"每日卖空追踪 | 德琪医药-B 12月08日卖空量成交20.4万股，卖空比例为13.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590362159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590362159?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182636,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月08日，跌1.13%，卖空量成交20.4万股，较上一交易日减少1.92%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163619979615b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163619979615b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","BK0188","03329","02096","BK1574","BK1587","BK1593","HK0000165453.HKD","06996","BK0082","BK1583","02268","600056","BK1147","BK0010","00013","BK0028","SG9999014674.SGD","BK1161","BK1191","LU2488822045.USD","BK0185","01530","BK1588","BK1141","BK0175"],"gpt_icon":0},{"id":"1171152247","title":"德琪医药（6996）更新11月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171152247","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171152247?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:26","pubTimestamp":1764843997,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2025年12月4日公布2025年11月股份变动月报。报告期截至2025年11月30日，公司注册股本维持在2,000,000,000股普通股，面值每股0.0001美元，总注册股本为200,000美元。期末已发行股份总数为679,244,132股，库存股份202,500股，整体保持不变。公司于报告期内未新增发行股份，亦未进行股份回购或注销。截至本月底，2020年股权激励计划及2022年受限制股份单位计划合计行使后可能发行的股份总数为55,780,257股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"gpt_icon":0},{"id":"2588019668","title":"德琪医药-B(06996)：希维奥®在香港获批用于治疗多发性骨髓瘤及弥漫大B细胞淋巴瘤两种新增适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019668","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588019668?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:38","pubTimestamp":1764751139,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)公布，香港特别行政区政府卫生署已批准希维奥® (塞利尼索)的两项补充新药上市申请(sNDA)，批准希维奥®联合硼替佐米和地塞米松(XVd)用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者;及希维奥®作为单药用于治疗复发性或难治性弥漫大B细胞淋巴瘤(rrDLBCL)成人患者，除另有说明外，其包含接受过至少两线系统性治疗且不符合造血干细胞移植的由滤泡性淋巴瘤引起的弥漫大B细胞淋巴瘤(DLBCL)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B(06996)：希维奥®在香港获批用于治疗多发性骨髓瘤及弥漫大B细胞淋巴瘤两种新增适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"1114028107","title":"港股生物医药股午后跌幅持续扩大，歌礼制药-B跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114028107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114028107?lang=zh_cn&edition=full","pubTime":"2025-12-03 13:12","pubTimestamp":1764738746,"startTime":"0","endTime":"0","summary":"12月3日，港股生物医药股午后跌幅持续扩大，$歌礼制药-B(01672)$跌超11%，$华领医药-B(02552)$跌近8%，$迈博药业-B(02181)$跌近7%，$德琪医药-B(06996)$跌超5%，$亚盛医药-B(06855)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","01477","BK1583","02552","06996","BK1515","01672","BK1161","BK1191","02181","BK1574"],"gpt_icon":0},{"id":"1182645191","title":"德琪医药-B在中国获得Atg-022（Cldn18.2 ADC）联合使用Keytruda®（Pembrolizumab）±化疗的I b/I II期研究的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1182645191","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182645191?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:00","pubTimestamp":1764666030,"startTime":"0","endTime":"0","summary":"德琪医药-B在中国获得Atg-022（Cldn18.2 ADC）联合使用Keytruda®（Pembrolizumab）±化疗的I b/I II期研究的IND批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"2588035332","title":"德琪医药-B(06996)：ATG-022联合KEYTRUDA®(帕博利珠单抗)±化疗的IB/II期研究于中国获授予IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588035332","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588035332?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:45","pubTimestamp":1764665132,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，中国国家药品监督管理局(国家药监局)已批准用于评估 ATG-022(CLDN18.2抗体药物偶联物ADC)联 合 MSD (Merck & Co., Inc., Rahway, NJ, USA)的抗PD 1疗法KEYTRUDA®(帕博利珠单抗)以及ATG-022联合帕博利珠单抗及化疗的Ib/II期CLINCH-2研究的研究性新药(IND)申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06996","BK1191","IND"],"gpt_icon":0},{"id":"2588765720","title":"每日卖空追踪 | 德琪医药-B 12月01日卖空量成交11.15万股，卖空比例为3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588765720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588765720?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577836,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间12月01日，跌1.33%，卖空量成交11.15万股，较上一交易日减少68.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163601a4c55275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163601a4c55275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06996","BK1191"],"gpt_icon":0},{"id":"2588720227","title":"德琪医药-B盘中异动 快速下挫5.09%报4.290港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588720227?lang=zh_cn&edition=full","pubTime":"2025-12-01 13:25","pubTimestamp":1764566737,"startTime":"0","endTime":"0","summary":"2025年12月01日下午盘13时25分，德琪医药-B股票出现波动，股价急速下挫5.09%。截至发稿，该股报4.290港元/股，成交量149.4万股，换手率0.22%，振幅7.74%。资金方面，该股资金流入249.304万港元，流出369.019万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.39%。其相关个股中，天大药业、康哲药业、白花油涨幅较大，振幅较大的相关个股有三爱健康集团、海王英特龙、德琪医药-B，振幅分别为12.50%、7.75%、7.52%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011325379523f9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011325379523f9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1191","BK1574"],"gpt_icon":0},{"id":"2588156743","title":"医药生物行业周报：关注血液净化器械领域国产替代机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2588156743","media":"光大证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588156743?lang=zh_cn&edition=full","pubTime":"2025-12-01 00:00","pubTimestamp":1764518400,"startTime":"0","endTime":"0","summary":"血液净化类高值医用耗材市场，进口产品占据70%以上的市场份额。透析机和透析器技术壁垒相对较高，我国市场仍是外资主导；透析管路国内产品的市占率接近50%，透析粉/液已基本实现进口替代。建议关注国产血液净化器械领域龙头公司山外山、威高血净、宝莱特、健帆生物、三鑫医疗、天益医疗等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201105635a71bd540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201105635a71bd540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","LU2097828557.USD","LU0455707207.USD","BK1161","LU2097828631.EUR","LU2097828714.EUR","LU2328871848.SGD","LU2488822045.USD","BK1583","LU1969619763.USD","LU2097828805.USD","LU0502904849.HKD","06996","01801","LU2097828474.EUR","LU2242644610.SGD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2584131925","title":"每日卖空追踪 | 德琪医药-B 11月20日卖空量成交12.75万股，卖空比例为8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131925","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131925?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627436,"startTime":"0","endTime":"0","summary":"德琪医药-B北京时间11月20日，涨6.44%，卖空量成交12.75万股，较上一交易日增加25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163745a4aecd15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163745a4aecd15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1574","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.0706},{"period":"1month","weight":-0.1084},{"period":"3month","weight":-0.4349},{"period":"6month","weight":0.258},{"period":"1year","weight":5.371},{"period":"ytd","weight":5.0769}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0167},{"period":"3month","weight":-0.0394},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.2836},{"period":"ytd","weight":0.2711}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.083349},{"month":2,"riseRate":0.2,"avgChangeRate":0.354616},{"month":3,"riseRate":0.4,"avgChangeRate":0.022852},{"month":4,"riseRate":0.4,"avgChangeRate":-0.055669},{"month":5,"riseRate":0.6,"avgChangeRate":0.040777},{"month":6,"riseRate":0.2,"avgChangeRate":-0.111296},{"month":7,"riseRate":0.2,"avgChangeRate":-0.000904},{"month":8,"riseRate":0.4,"avgChangeRate":-0.030428},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020432},{"month":10,"riseRate":0.4,"avgChangeRate":0.032822},{"month":11,"riseRate":0.6,"avgChangeRate":0.05603},{"month":12,"riseRate":0.333333,"avgChangeRate":0.003358}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}